A detailed history of Capital Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Management Corp holds 1,086 shares of ABBV stock, worth $186,292. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,086
Holding current value
$186,292
% of portfolio
0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$163.84 - $199.33 $177,930 - $216,472
1,086 New
1,086 $214,000
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $197,377 - $224,893
1,235 New
1,235 $224,000
Q3 2018

Oct 31, 2018

SELL
$88.91 - $98.84 $246,458 - $273,984
-2,772 Closed
0 $0
Q1 2018

Apr 25, 2018

SELL
$92.01 - $123.21 $46,005 - $61,605
-500 Reduced 15.28%
2,772 $262,000
Q3 2017

Nov 01, 2017

BUY
$69.85 - $89.22 $228,549 - $291,927
3,272
3,272 $291,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Management Corp Portfolio

Follow Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Capital Management Corp with notifications on news.